A Fresh, Affordable Pathway to Compliance and Quality For the Compounding Pharmacy Industry
The ONLY Risk-Based Auditing and Accreditation Model in Compounding
Experienced Auditors > Commitment to Excellence > Far Lower Cost
Our Mission:
-
Objectively assess and assist 503A pharmacies
-
Prepare pharmacies for any other regulatory agency that might walk in the door
-
Improve your pharmacy's efficiency and effectiveness through ideas, information, and consultative assistance
-
Perform all of this at a reasonable price
We Provide:
-
A realistic assessment of your compliance with relevant regulatory standards
-
Recommendations and information that allow you to improve your internal efficiency and external patient care
-
The opportunity to participate in ongoing compliance programs and a first-ever 503A benchmarking project

Key Attributes:
503A Experts
Audits are conducted by true 503A experts with proven auditing skills. They must have worked in, owned, or have deep auditing experience with compounding pharmacies.
Risk-Based Approach
Follows FDA's Q9(R1) Quality Risk Management approach versus a stricly checklist methodology.
Client Centered Approach
We actively provide pharmacies with information and suggestions that will improve their efficiency and effectiveness.
Our Process:
1. Intake and onboarding
2. Preliminary review of submitted evidence
3. On-site thorough Risk-Based audit
4. Accreditation
5. Ongoing interactions, assistance, and support
Low Cost / High Quality
Our low overhead costs allow us to drastically undercut competitor pricing.
See the "Our Method" page for an explanation of "risk-based" auditing and accreditation, and why it is a superior method for protecting your patients, your employees, and your pharmacy.
Coalition Members
L. Rad Dillon, R.Ph., M.A., ASQ SSGB, GMPro, ASQ CQA
Founder, Coalition for Compounding Excellence
Joseph Navarra, R.Ph., FACA, FAPC
Owner, Town Total Compounding Center
David Miller, RPh, PhD, FAPC, FACA
Chief Formulation Scientist & Owner, Keystone Pharmacy
Scott Popyk, RPh, MBA
CEO of Healing Dose Compounding Pharmacy
Danny Barnes, PharmD, BCSCP, RPh
Chief Pharmacy Officer/President Triangle Compounding Pharmacy Inc.
Jerry Eubanks, RPh
President, Pestle - Pharmacy Compliance System
Gary McCrory, RPh, FACA, CCN
Consultant pharmacist
Rick Ferris, PharmD, ND, MBA, MPH
Consultant pharmacist, functional medicine practitioner
Ralph McBride, RPh, MBA, BCSCP
Strategic Sourcing Manager, AuthoraCare Collective
Lawrence Curtis, RPh
Owner, Center for Pharmaceutical Compounding
Barbara Petroff, MS, RPh, FASHP, BCSCP, FNHIA, CAC, CSPP, IgCP
Principal Shawler Petroff LLC
Thomas Kupiec, Ph.D., Pharmaceutical Sciences
President and Managing Editor, International Journal of Pharmaceutical Compounding
Anthony Grzib, RPh
Vice President of RegulatoryAffairs, Revelation Pharma
Brenda Gray, PharmD
Consultant pharmacist
Mike Rigas, Pharm.D
Chief Clinical Officer, Emeritus, KabaFusion
Samantha Tricarico, CPhT, CSPT
Compounding Pharmacy and Education Specialist
Edie Gigot, RN, MS, MBA
Founder and CEO, AdvisorWoRx
Stanley Chamallas, RPh, FASHP, FNHIA
Director of Process Improvement for Home Care, Pneuma Systems Inc
Emily Durham, MS, CPhT
Director of Business Development, Covetrus
Sky Countryman, B.S., Chemistry
Chief Executive Officer at HeliosRx Pharmacy
Richard B Moon, PharmD, FAPC
Founder, Pharmacy Innovations Group
Timothy Safley, MBA
Owner, Safley Health Care Consulting
Michael Magee, RPh, ASQ CPGP
Owner and Principal Consultant, Kenformete Solutions, LLC
Amy H. Snow, MHS, CIH, CSP
Senior Manager Industrial Hygiene, Trinity Life Sciences
Michael R. Alexander, J.D.
Shareholder, Brown & Fortunato
CONTACT US
